longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Hengrui Pharma

600276

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 39.55, below the reasonable range, cheaper than 98.15% of the time in the past 5 years, and the industry ranks 91/221, the industry Median 24.14.

39.55xP/E
¥46.04Stock price
¥1.16Earnings per share
39.55xP/E
Stock price¥46.04Earnings per share¥1.16

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
57.18x
Typical range
50.44x–68.15x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 24.14x
021426384

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 24.14x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
600276SHHengrui Pharma
39.55x17.99%¥305.58B
002422SZKELUN PHARMA
36.95x15.33%¥67.58B
600085SHTRT
33.45x7.45%¥32.45B
000739SZAPELOA
33.83x23.79%¥28.75B
600329SHDRTG
31.96x51.62%¥27.11B
600521SHHuahaipharm
39.73x305.56%¥24.94B
002262SZNHWA
20.17x14.76%¥22.13B
603456SHJiuzhou Pharma
24.14x12.93%¥14.28B
603707SHNKF
26.40x11.11%¥12.75B
002019SZYifan Pharmaceutical
38.61x12.12%¥11.71B
600420SHSHYNDEC
20.59x--¥11.23B
600572SHCONBA
22.30x--¥11.12B
300357SZWolwo Pharma
25.33x18.88%¥10.57B
002626SZKingdomway
38.94x56.36%¥10.23B
688076SHSinopep
38.91x91.51%¥9.24B
300401SZGARDEN BIOPHARMA
33.27x56.86%¥9.16B
688513SHEASTON BIOPHARMACEUTICALS
31.82x0.00%¥8.82B
002332SZXJZY
22.20x5.56%¥8.57B
002550SZQianhong Bio-pharma
28.77x--¥8.45B
002437SZGLORIA PHARMA.
20.77x--¥8.34B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.